113 related articles for article (PubMed ID: 2283288)
21. A disputed spleen.
Brahams D
Lancet; 1988 Nov; 2(8620):1151-2. PubMed ID: 2903372
[TBL] [Abstract][Full Text] [Related]
22. Cells, sales, and royalties: the patient's right to a portion of the profits.
Danforth MT
Yale Law Policy Rev; 1988; 6(1):179-202. PubMed ID: 11650242
[No Abstract] [Full Text] [Related]
23. Court rules cells are the patient's property.
Crawford M
Science; 1988 Aug; 241(4866):653-4. PubMed ID: 3399896
[No Abstract] [Full Text] [Related]
24. Human tissue research: who owns the results?
Wagner AB
J Pat Trademark Off Soc; 1987 Jun; 69(6):329-52. PubMed ID: 11649984
[No Abstract] [Full Text] [Related]
25. An institutional policy on the right to benefit from the commercialization of human biological material.
Prentice ED; Wiltse JC; Sharp JG; Antonson DL
Law Med Health Care; 1990; 18(1-2):162-7. PubMed ID: 2374448
[No Abstract] [Full Text] [Related]
26. Legal & ethical safeguards: protection of society's most vulnerable participants in a commercialized organ transplantation system.
Banks GJ
Am J Law Med; 1995; 21(1):45-110. PubMed ID: 7573083
[No Abstract] [Full Text] [Related]
27. Case comment: Moore v. Regents of the University of California.
Bergman HR
Am J Law Med; 1992; 18(1-2):127-45. PubMed ID: 1621701
[TBL] [Abstract][Full Text] [Related]
28. Who owns the body? On the ethics of using human tissues for commercial purposes.
Murray TH
IRB; 1986; 8(1):1-5. PubMed ID: 11649702
[No Abstract] [Full Text] [Related]
29. Second thoughts about U.S. Patent #4,438,032.
Burrows B
Bull Med Ethics; 1997 Jan; No. 124():11-4. PubMed ID: 11655049
[No Abstract] [Full Text] [Related]
30. Consent to use of discarded tissues: another impact of AIDS.
Holder AR
IRB; 1987; 9(5):10-1. PubMed ID: 11649897
[No Abstract] [Full Text] [Related]
31. Commercial development of human cell lines--property, ethics, and conflict of interest.
Golde DW
N Engl J Med; 1991 Jun; 324(24):1745-6. PubMed ID: 2034257
[No Abstract] [Full Text] [Related]
32. Property, progeny, and patents.
Knowles LP
Hastings Cent Rep; 1999; 29(2):38-40. PubMed ID: 10321342
[No Abstract] [Full Text] [Related]
33. Research that could yield marketable products from human materials: the problem of informed consent.
Levine RJ
IRB; 1986; 8(1):6-7. PubMed ID: 11649703
[No Abstract] [Full Text] [Related]
34. Property rights and payment to patients for cell lines derived from human tissues: an economic analysis.
Greenberg W; Kamin D
Soc Sci Med; 1993 Apr; 36(8):1071-6. PubMed ID: 8475423
[TBL] [Abstract][Full Text] [Related]
35. Mo cell case has its first court hearing.
Culliton BJ
Science; 1984 Nov; 226(4676):813-4. PubMed ID: 6494909
[TBL] [Abstract][Full Text] [Related]
36. An alternative to property rights in human tissue.
Swain MS; Marusyk RW
Hastings Cent Rep; 1990; 20(5):12-5. PubMed ID: 2228577
[TBL] [Abstract][Full Text] [Related]
37. Conflict + interest: financial incentives and informed consent in human subject research.
Benbow S
Notre Dame J Law Ethics Public Policy; 2003; 17(1):181-215. PubMed ID: 14986653
[No Abstract] [Full Text] [Related]
38. Who should have rights to a patient's cells?
Sun M
Science; 1986 Feb; 231(4738):543-4. PubMed ID: 3945799
[No Abstract] [Full Text] [Related]
39. Toward the right of commerciality: recognizing property rights in the commercial value of human tissue.
Hardiman R
UCLA Law Rev; 1986 Oct; 34(1):207-64. PubMed ID: 11659048
[No Abstract] [Full Text] [Related]
40. Owning our bodies: an examination of property law and biotechnology.
Gold R
San Diego Law Rev; 1995; 32(4):1167-247. PubMed ID: 11656846
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
